drug

eflornithine

1 story · latest Nov 6, 2026

Follow eflornithine. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Dec 2023 · NDA215500
Brand: Iwilfin

Also known as

eflornithine hydrochloride

Timeline

FDA approved eflornithine for high-risk neuroblastoma in December 2023

Nov 6Regulatory decisioneflornithine

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.